Innovative Strategies for Target Identification

Speaker - Funded(s)

• 

  Matthew Coelho, Dr.

  Dr.
  Wellcome Sanger Institute, United Kingdom
• 

  Ulrike Künzel, MSc, PhD (she/her/hers)

  Associate Director
  AstraZeneca, United Kingdom

Speaker - Not Funded(s)

• GR

  Gabriel Rosser, DPhil (he/him/his)

  Lead Bioinformatics Data Scientist
  BenevolentAI, United Kingdom

Presentations:

• 14:30 – 15:00 CET

  The application of arrayed CRISPR screening for target identification in primary cells
  

  Ulrike Künzel, MSc, PhD (she/her/hers) – AstraZeneca
• 15:00 – 15:30 CET

  High-throughput functional genomics using CRISPR base editing in cancer cells
  

  Matthew Coelho, Dr. – Wellcome Sanger Institute
• 15:30 – 16:00 CET

  AI-augmented mechanistic target identification at BenevolentAI
  

  Gabriel Rosser, DPhil (he/him/his) – BenevolentAI